Received Apr 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | N/A | NN3038 | IM / LA |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | NN3038 | LA |
neuropathy; left foot was arched completely back; sunburn-like rash on the top of both feet and on inside of both wrists; This is a spontaneous report received from a Consumer or other non HCP. A 71-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 02Mar2026 at 15:00 as dose 1, single (Lot number: NN3038), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Lupus" (unspecified if ongoing); "Osteoarthritis" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing); "Salzmann's Nodules" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: CELLCEPT [MYCOPHENOLATE MOFETIL HYDROCHLORIDE], start date: May2006; PLAQUENIL [HYDROXYCHLOROQUINE SULFATE], start date: May1986; REPATHA, start date: Sep2025; TRYPTYR, start date: Dec2025; QUNOL ULTRA COQ10, start date: Aug2024; CALTRATE [CALCIUM CARBONATE], start date: Jun1999; DIAZEPAM, start date: May2019; IBUPROFEN, start date: Apr2025; COLACE, start date: Jul2008. Past drug history included: Talwin, reaction(s): "Known allergies: Talwin"; Thimerosal, reaction(s): "Known allergies: Thimerosal"; Celebrex, reaction(s): "Known allergies: Celebrex"; Meloxicam, reaction(s): "Known allergies: Meloxicam"; Demerol, reaction(s): "Known allergies: Demerol"; Keflex, reaction(s): "Known allergies: Keflex"; Erythromycin, reaction(s): "Known allergies: Erythromycin"; Azithromycin, reaction(s): "Known allergies: Azithromycin". Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 immunization. The following information was reported: NEUROPATHY PERIPHERAL (medically significant) with onset 03Mar2026 at 03:00, outcome "recovering", described as "neuropathy"; FOOT DEFORMITY (medically significant) with onset 2026, outcome "recovering", described as "left foot was arched completely back"; RASH ERYTHEMATOUS (non-serious) with onset 2026, outcome "recovering", described as "sunburn-like rash on the top of both feet and on inside of both wrists". The patient underwent the following laboratory tests and procedures: Pain assessment: (2026) 7 or 8, notes: lessened slightly. Therapeutic measures were taken as a result of neuropathy peripheral, foot deformity, rash erythematous. Clinical course: 12 hours after receiving COVID booster, she awoke with burning pain radiating throughout her body. Her left foot was arched completely back, severe cramping in her right calf. Pain and cramping was so severe, she could not get to the bathroom. Over the next three days, the pain lessened slightly to a 7 or 8. She developed a sunburn-like rash on the top of both feet and on inside of both wrists. This searing pain would start and then radiate, sometimes lasting from a few minutes to an hour. It occurred randomly through the day. The cramping in her lower legs and feet also occurred randomly but was particularly bothersome at night. Symptoms have persisted over the past 7 1/2 weeks, but very gradually they have improved. Her rheumatologist prescribed prednisone on 21Apr2026, which she took over the next 18 days. It had no effect. Doctor then diagnosed as neuropathy. Currently, very slight redness on feet, pain only occasionally. Vaccine location reported as upper left arm. The patient did not receive other vaccine on same date and in last four weeks.
Medical History/Concurrent Conditions: Fibromyalgia; Lupus erythematosus; Osteoarthritis; Salzmann nodular degeneration; Sulfonamide allergy
CELLCEPT [MYCOPHENOLATE MOFETIL HYDROCHLORIDE]; PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; REPATHA; TRYPTYR; QUNOL ULTRA COQ10; CALTRATE [CALCIUM CARBONATE]; DIAZEPAM; IBUPROFEN; COLACE
Test Date: 2026; Test Name: Pain; Result Unstructured Data: Test Result:7 or 8; Comments: lessened slightly